ZTS

Q1 in Review: The Top 3 IPO Trends

The first quarter's in the books and turned out to be a solid one for IPOs. Let's take a look at the three sectors that kicked off 2013 the strongest. More 

3 Dow Jones Stocks to Buy

Investors would be wise to care less about the Dow Jones and more about its individual components -- namely, these three attractive blue chips. More 

Bausch & Lomb Prepping to Go Public?

A report says private equity investor Warburg Pincus is interviewing investment banks about a potential Bausch & Lomb IPO. More 

Top 10 Dow Dividend Stocks for February

Income investors could do a lot worse than buying into these venerable blue chips -- especially the stock that continues to hold the crown. More 

Boise Cascade Leads This Week’s 7 IPOs

Wood products and building materials company Boise Cascade leads 7 planned IPOs that also include an MLP, a drilling company and a Jamaican bank. More 

Pfizer Spinoff Zoetis Zooms on Its IPO

Pfizer's spun-off animal health division, Zoetis, raised $2.2 billion in its initial public offering, then enjoyed a strong reception in early Friday trading. More 

Zoetis: The Biggest IPO Since Facebook

Pfizer's animal health division, Zoetis, could raise more than $2 billion, making it the largest IPO since Facebook. Here's a look at the Zoetis deal, as well as three others on tap for this week. More